Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-25 @ 3:29 AM
NCT ID:
NCT05056805
Eligibility Criteria:
Inclusion Criteria:
* Pancreatic or gastric adenocarcinoma, biopsy-proven
* Have completed or are within 2 weeks of completion of preoperative chemoradiotherapy either on- or off-protocol
* Anticipated to undergo potentially curative resection in 4-6 weeks from enrollment
* Able to understand the description of the study and willing to participate
* Able to understand the exercise program
* Able to independently maintain daily exercise logs via Pt Pal -iOS, Android or desktop web browser on their own personal device
* Telephone or email access and agreement to engage with the research personnel via phone or email
* Meet all screening requirements, including physician clearance
* \>= age 18
Exclusion Criteria:
* Non-English speaking
* Has participated in moderate to high intensity strengthening exercises at least two times per week within the past four weeks prior to enrollment
* Unable to complete the baseline assessment questionnaires or functional assessments
* Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease (New York Heart Association functional class III or IV)
* Recent fracture or acute musculoskeletal injury that precludes the ability to weight bear fully on all 4 limbs in order to participate in an exercise intervention
* Numeric pain rating scale of \>= 7 out of 10
* Myopathic or rheumatologic disease that impacts physical function
* Recurrent cancer following prior resection
* \< age 18
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05056805
Study Brief:
Protocol Section:
NCT05056805